Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticLeukemiaLiver TransplantationTransplantation ChimeraHematopoietic Stem CellsGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingStem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisStem Cell TransplantationRecurrenceMice, Inbred C57BLCombined Modality TherapyRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationHematologic NeoplasmsTreatment OutcomeImmunosuppressive AgentsRemission InductionGraft RejectionTime FactorsPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionImmunosuppressionLymphocyte DepletionLymphoma, Non-HodgkinLeukocyte TransfusionAcute DiseaseHeart TransplantationColony-Forming Units AssayChimeraSevere Combined ImmunodeficiencyT-LymphocytesMyelodysplastic SyndromesSurvival AnalysisHLA AntigensRetrospective StudiesLung TransplantationHematologic DiseasesCyclosporineActuarial AnalysisBone DensityLymphocyte TransfusionCell DifferentiationAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyCarmustineOrgan TransplantationPancytopeniaGraft vs Tumor EffectFollow-Up StudiesGraft vs Leukemia EffectCytarabineSurvival RateLeukocyte CountCytomegalovirus InfectionsGranulocyte Colony-Stimulating FactorFlow CytometryCells, CulturedSpleenMelphalanBone ResorptionMice, Inbred BALB CDisease-Free SurvivalEtoposideMultiple MyelomaAntigens, CD34LymphomaFatal OutcomeCord Blood Stem Cell TransplantationMice, KnockoutCell TransplantationHodgkin DiseasePeripheral Blood Stem Cell TransplantationPrognosis